Fluphenazine Hcl
Rank #461 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$16.0M
Total Cost
73,051
Total Claims
$16.0M
Total Cost
2,824
Prescribers
$220
Cost per Claim
1,430
Beneficiaries
77,721
30-Day Fills
$5,679
Avg Cost/Provider
26
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$16.0M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $16.0M total
🔎 Data Overview
Average cost of $11,215 per patient per year. Medications at this price point significantly impact patient out-of-pocket costs and Medicare spending.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Fluphenazine Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Enrique Casuso | Geriatric Psychiatry | Miami, FL | 577 | $253K |
| 2 | Shephali Patel | Psychiatry | Chicago, IL | 704 | $79K |
| 3 | Henry Emerle | Psychiatry | Davenport, IA | 151 | $79K |
| 4 | Phillip Rowden | Psychiatry & Neurology | Olla, LA | 83 | $63K |
| 5 | Mary Galonski | Psychiatry | Kittanning, PA | 157 | $61K |
| 6 | Shobin Oommen | Psychiatry | Stroudsburg, PA | 193 | $61K |
| 7 | Jagadeeswara Musunuru | Psychiatry | Fond Du Lac, WI | 153 | $61K |
| 8 | Patricia Gagnon | Physician Assistant | Augusta, ME | 147 | $50K |
| 9 | Ian Starr | Psychiatry | Portland, OR | 83 | $44K |
| 10 | Charles Lewis | Psychiatry | Little Rock, AR | 98 | $42K |
| 11 | Paula Sweet | Nurse Practitioner | Jasper, AL | 135 | $42K |
| 12 | Vivek Gupta | Internal Medicine | Chicago, IL | 139 | $41K |
| 13 | Edward Zuzarte | Psychiatry | Baltimore, MD | 107 | $41K |
| 14 | Sudhir Lingnurkar | Psychiatry | Warren, MI | 296 | $39K |
| 15 | Joshua Shua-Haim | Geriatric Medicine | Manchester, NJ | 111 | $39K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 458 | Bosentan (Bosentan) | $16.5M | 2,765 |
| 459 | Telmisartan (Telmisartan) | $16.4M | 334,601 |
| 460 | Letermovir (Prevymis) | $16.1M | 2,144 |
| 461 | Fluphenazine Hcl (Fluphenazine Hcl) | $16.0M | 73,051 |
| 462 | Nivolumab (Opdivo) | $16.0M | 1,275 |
| 463 | Leflunomide (Leflunomide) | $16.0M | 205,765 |
| 464 | Hydrocortisone (Hydrocortisone) | $15.9M | 762,398 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology